1.7mg semaglutide to tirzepatide Dosing & Prescribing is semaglutide a brand name

Here is the dose ladder

For the primary analysis, aITCs were based on results for the efficacy estimand (referred to as the trial product estimand in SUSTAIN FORTE), which was defined as the treatment effect among all patients who underwent randomization and received at least one dose of the study medication, excluding the data after the start of rescue therapy (for persistent hyperglycaemia) or study drug discontinuation

And while it is progress, the actual number was lowering risk from 8% in the placebo group to 6.5% in the treatment group or only 1.5% absolute risk reduction

Attach the needle

Sources : Jastreboff AM, Aronne LJ, Ahmad NN, et al